Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Morrow

Showing results (301-310 of 942) with videos related to

Pageof 95
Sort By:
The Clinical Neuropsychologist|September 11, 2010
Predicting loss of employment over three years in multiple sclerosis: clinically meaningful cognitive declineSarah A Morrow, Allison Drake, Robert Zivadinov, et al.
JAMA Neurology|March 7, 2018
Effect of Treating Acute Optic Neuritis With Bioequivalent Oral vs Intravenous Corticosteroids: A Randomized Clinical TrialSarah A Morrow, J Alexander Fraser, Chad Day, et al.
Cardiovascular Engineering (Dordrecht, Netherlands)|March 14, 2009
Spectral energy of ECG morphologic differences to predict deathZeeshan Syed, Phil Sung, Benjamin M Scirica, et al.
Physiological Measurement|May 12, 2005
Evaluating the dynamic performance of a fibre optic pressure microsensorShigao Chen, Cristina Pislaru, Randall R Kinnick, et al.
The Journal of Clinical Endocrinology and Metabolism|June 23, 2012
Glucokinase activators AZD6370 and AZD1656 do not affect the central counterregulatory response to hypoglycemia in healthy malesEnsio Norjavaara, Hans Ericsson, Folke Sjöberg, et al.
European Heart Journal|January 17, 2002
An integrated clinical approach to predicting the benefit of tirofiban in non-ST elevation acute coronary syndromes. Application of the TIMI Risk Score for UA/NSTEMI in PRISM-PLUSD A Morrow, E M Antman, S M Snapinn, et al.
Clinical Cardiology|December 12, 2019
Respiratory support in acute heart failure with preserved vs reduced ejection fractionThomas S Metkus, Robert Scott Stephens, Steven Schulman, et al.
American Heart Journal|June 20, 2006
Evaluation of a novel anti-ischemic agent in acute coronary syndromes: design and rationale for the Metabolic Efficiency with Ranolazine for Less Ischemia in Non-ST-elevation acute coronary syndromes (MERLIN)-TIMI 36 trialDavid A Morrow, Benjamin M Scirica, Ewa Karwatowska-Prokopczuk, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|June 22, 2019
Utilization and outcomes of early respiratory support in 6.5 million acute heart failure hospitalizationsThomas S Metkus, Robert Scott Stephens, Steven Schulman, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|July 8, 2017
Canadian Normative Data for Minimal Assessment of Cognitive Function in Multiple SclerosisLisa A S Walker, David Marino, Jason A Berard, et al.
Pageof 95

Showing results (301-310 of 942) with videos related to

Sort By:
Pageof 95
The Clinical Neuropsychologist|September 11, 2010
Predicting loss of employment over three years in multiple sclerosis: clinically meaningful cognitive declineSarah A Morrow, Allison Drake, Robert Zivadinov, et al.
JAMA Neurology|March 7, 2018
Effect of Treating Acute Optic Neuritis With Bioequivalent Oral vs Intravenous Corticosteroids: A Randomized Clinical TrialSarah A Morrow, J Alexander Fraser, Chad Day, et al.
Cardiovascular Engineering (Dordrecht, Netherlands)|March 14, 2009
Spectral energy of ECG morphologic differences to predict deathZeeshan Syed, Phil Sung, Benjamin M Scirica, et al.
Physiological Measurement|May 12, 2005
Evaluating the dynamic performance of a fibre optic pressure microsensorShigao Chen, Cristina Pislaru, Randall R Kinnick, et al.
The Journal of Clinical Endocrinology and Metabolism|June 23, 2012
Glucokinase activators AZD6370 and AZD1656 do not affect the central counterregulatory response to hypoglycemia in healthy malesEnsio Norjavaara, Hans Ericsson, Folke Sjöberg, et al.
European Heart Journal|January 17, 2002
An integrated clinical approach to predicting the benefit of tirofiban in non-ST elevation acute coronary syndromes. Application of the TIMI Risk Score for UA/NSTEMI in PRISM-PLUSD A Morrow, E M Antman, S M Snapinn, et al.
Clinical Cardiology|December 12, 2019
Respiratory support in acute heart failure with preserved vs reduced ejection fractionThomas S Metkus, Robert Scott Stephens, Steven Schulman, et al.
American Heart Journal|June 20, 2006
Evaluation of a novel anti-ischemic agent in acute coronary syndromes: design and rationale for the Metabolic Efficiency with Ranolazine for Less Ischemia in Non-ST-elevation acute coronary syndromes (MERLIN)-TIMI 36 trialDavid A Morrow, Benjamin M Scirica, Ewa Karwatowska-Prokopczuk, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|June 22, 2019
Utilization and outcomes of early respiratory support in 6.5 million acute heart failure hospitalizationsThomas S Metkus, Robert Scott Stephens, Steven Schulman, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|July 8, 2017
Canadian Normative Data for Minimal Assessment of Cognitive Function in Multiple SclerosisLisa A S Walker, David Marino, Jason A Berard, et al.
Pageof 95